Skip to main content Accessibility help
×
Home

Use of atomoxetine in eating disorders. A case report

  • R. Landera Rodríguez (a1), M. Juncal Ruiz (a1), L. Sánchez Blanco (a1), G. Pardo de Santayana Jenaro (a1), O. Porta Olivares (a1), M. Gómez Revuelta (a2), I. Madrazo del Río Hortega (a1), M. Pérez Herrera (a1), D. Abejas Díez (a1) and J. González Gomez (a1)...

Abstract

Introduction

Eating disorders (EDs) are an important public health problem and not all patients respond adequately to psychotherapy. In the last decade, researchers report a significant comorbidity of EDs and attention-deficit/hyperactivity disorder (ADHD), especially binge eating disorder and bulimia nervosa. Some studies postulate the hypothesis of a common neurobiological substrate, such as noradrenergic pathways among others.

Objectives

To revise the possible use of atomoxetine, a highly selective noradrenergic reuptake inhibitor, for the treatment of EDs.

Methods

We describe the effect of atomoxetine in a young woman with purging disorder and history of ADHD in childhood added to cognitive behavioural therapy (CBT).

Results

patient had selective/restrictive eating behaviours, daily purges and occasional binges for last five years. At age 14 she was diagnosed with ADHD by impulsivity/aggressiveness and poor school performance, but she did not take drugs and left medical consultations. She came to our specific unit of EDs in november-2015. Her BMI was 24.88 kg/m2. We initiated CBT and atomoxetine (80 mg/day). In this first year of treatment binges and purges have disappeared and exposure to new foods and body image have improved partially. We found clear improvement in mood, motivation and attention/concentration in relation with introduction of atomoxetine. These facts have positive impact on the clinical evolution. Her current BMI is 26.90 kg/m2.

Conclusions

Identify comorbid ADHD to assess the use of specific drugs for this disorder could be beneficial in the treatment and prognosis of EDs. However, more studies are needed to determine effectivenes, particularly of non-stimulant drugs.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Use of atomoxetine in eating disorders. A case report
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Use of atomoxetine in eating disorders. A case report
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Use of atomoxetine in eating disorders. A case report
      Available formats
      ×

Copyright

Corresponding author

*Corresponding author.

Use of atomoxetine in eating disorders. A case report

  • R. Landera Rodríguez (a1), M. Juncal Ruiz (a1), L. Sánchez Blanco (a1), G. Pardo de Santayana Jenaro (a1), O. Porta Olivares (a1), M. Gómez Revuelta (a2), I. Madrazo del Río Hortega (a1), M. Pérez Herrera (a1), D. Abejas Díez (a1) and J. González Gomez (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Use of atomoxetine in eating disorders. A case report

  • R. Landera Rodríguez (a1), M. Juncal Ruiz (a1), L. Sánchez Blanco (a1), G. Pardo de Santayana Jenaro (a1), O. Porta Olivares (a1), M. Gómez Revuelta (a2), I. Madrazo del Río Hortega (a1), M. Pérez Herrera (a1), D. Abejas Díez (a1) and J. González Gomez (a1)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *